Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Diabetes Mellitus
- Glucose Metabolism Disorders
- Prediabetes
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
After being informed about the study and potential risks, all patients giving written informed consent wear a continuous glucose monitoring device ("iPro2" professional continuous glucose monitoring, Medtronic?, California, USA) and smart band ("Fitbit Inspire HR", Fitbit?, California, USA) for 1 we...
After being informed about the study and potential risks, all patients giving written informed consent wear a continuous glucose monitoring device ("iPro2" professional continuous glucose monitoring, Medtronic?, California, USA) and smart band ("Fitbit Inspire HR", Fitbit?, California, USA) for 1 week. During this period, all patients are tested oral glucose tolerance test and take a standard diet (calorie calculated) at morning. The patient's data from this study is compared to a predicted values by mathematical analysis model for diabetes prevention.
Tracking Information
- NCT #
- NCT04369833
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Sang soo Kim, Master Pusan National University Hospital
Get Well Soon